The global tonsillitis drugs industry is currently navigating a period of steady growth, driven by a combination of rising pediatric infections, the evolution of antibiotic formulations, and a post-pandemic resurgence in elective medical consultations. As of 2025, the market is increasingly focused on addressing antimicrobial resistance (AMR) while expanding access to fast-acting symp... https://www.databridgemarketresearch.com/reports/global-tonsillitis-drugs-market